Literature DB >> 27699630

A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.

Kristen A McLaurin1, Landhing M Moran1, Hailong Li1, Rosemarie M Booze1, Charles F Mactutus2.   

Abstract

Approximately 50 % of HIV-1 seropositive individuals develop HIV-1 associated neurocognitive disorders (HAND), which commonly include alterations in executive functions, such as inhibition, set shifting, and complex problem solving. Executive function deficits in HIV-1 are fairly well characterized, however, relatively few studies have explored the elemental dimensions of neurocognitive impairment in HIV-1. Deficits in temporal processing, caused by HIV-1, may underlie the symptoms of impairment in higher level cognitive processes. Translational measures of temporal processing, including cross-modal prepulse inhibition (PPI), gap-prepulse inhibition (gap-PPI), and gap threshold detection, were studied in mature (ovariectomized) female HIV-1 transgenic (Tg) rats, which express 7 of the 9 HIV-1 genes constitutively throughout development. Cross-modal PPI revealed a relative insensitivity to the manipulation of interstimulus interval (ISI) in HIV-1 Tg animals in comparison to control animals, extending previously reported temporal processing deficits in HIV-1 Tg rats to a more advanced age, suggesting the permanence of temporal processing deficits. In gap-PPI, HIV-1 Tg animals exhibited a relative insensitivity to the manipulation of ISI in comparison to control animals. In gap-threshold detection, HIV-1 Tg animals displayed a profound differential sensitivity to the manipulation of gap duration. Presence of the HIV-1 transgene was diagnosed with 91.1 % accuracy using gap threshold detection measures. Understanding the generality and permanence of temporal processing deficits in the HIV-1 Tg rat is vital to modeling neurocognitive deficits observed in HAND and provides a key target for the development of a diagnostic screening tool.

Entities:  

Keywords:  Diagnostic screening tool; HIV-1 associated neurocognitive disorders; Prepulse inhibition; Temporal processing

Mesh:

Year:  2016        PMID: 27699630      PMCID: PMC5316491          DOI: 10.1007/s11481-016-9711-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  55 in total

1.  Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge.

Authors:  Landhing M Moran; Michael Y Aksenov; Rosemarie M Booze; Katy M Webb; Charles F Mactutus
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

2.  Neurotological auditory brain stem response findings in human immunodeficiency virus-positive patients without neurologic manifestations.

Authors:  E Castello; N Baroni; E Pallestrini
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-12       Impact factor: 1.547

3.  Using intracranial electrical stimulation to study the timing of prepulse inhibition of the startle reflex.

Authors:  L Li; J S Yeomans
Journal:  Brain Res Brain Res Protoc       Date:  2000-02

4.  An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.

Authors:  W Reid; M Sadowska; F Denaro; S Rao; J Foulke; N Hayes; O Jones; D Doodnauth; H Davis; A Sill; P O'Driscoll; D Huso; T Fouts; G Lewis; M Hill; R Kamin-Lewis; C Wei; P Ray; R C Gallo; M Reitz; J Bryant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

5.  Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

Authors:  Igor Grant; Donald R Franklin; Reena Deutsch; Steven P Woods; Florin Vaida; Ronald J Ellis; Scott L Letendre; Thomas D Marcotte; J H Atkinson; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; John A McCutchan; Ian Abramson; Anthony Gamst; Christine Fennema-Notestine; Davey M Smith; Robert K Heaton
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

6.  Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures.

Authors:  Sylvia Fitting; Rosemarie M Booze; Charles F Mactutus
Journal:  Brain Res       Date:  2008-07-17       Impact factor: 3.252

7.  ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy.

Authors:  Linda L Chao; Joselyn A Lindgren; Derek L Flenniken; Michael W Weiner
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

8.  The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART.

Authors:  Jinsong Peng; Michael Vigorito; Xiangqian Liu; Dunjing Zhou; Xiongwen Wu; Sulie L Chang
Journal:  J Neuroimmunol       Date:  2009-11-13       Impact factor: 3.478

9.  Delayed latency of the event-related brain potential P3A component in HIV disease. Progressive effects with increasing cognitive impairment.

Authors:  G Fein; C A Biggins; S MacKay
Journal:  Arch Neurol       Date:  1995-11

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more
  16 in total

1.  Temporal processsing demands in the HIV-1 transgenic rat: Amodal gating and implications for diagnostics.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2016-12-28       Impact factor: 2.457

2.  Evolution of the HIV-1 transgenic rat: utility in assessing the progression of HIV-1-associated neurocognitive disorders.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2017-07-20       Impact factor: 2.643

3.  Morphine-potentiated cognitive deficits correlate to suppressed hippocampal iNOS RNA expression and an absent type 1 interferon response in LP-BM5 murine AIDS.

Authors:  Virginia D McLane; Saurabh Kumar; Reno Leeming; Sanjay Rau; Colin L Willis; Ling Cao
Journal:  J Neuroimmunol       Date:  2018-03-06       Impact factor: 3.478

4.  Aging alters voltage-gated calcium channels in prefrontal cortex pyramidal neurons in the HIV brain.

Authors:  Christina E Khodr; Lihua Chen; Lena Al-Harthi; Xiu-Ti Hu
Journal:  J Neurovirol       Date:  2017-10-31       Impact factor: 2.643

5.  Aging and HIV-1 alter the function of specific K+ channels in prefrontal cortex pyramidal neurons.

Authors:  Lihua Chen; Christina E Khodr; Lena Al-Harthi; Xiu-T Hu
Journal:  Neurosci Lett       Date:  2019-06-27       Impact factor: 3.046

6.  Diagnostic and prognostic biomarkers for HAND.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

7.  The Power of Interstimulus Interval for the Assessment of Temporal Processing in Rodents.

Authors:  Kristen A McLaurin; Landhing M Moran; Hailong Li; Rosemarie M Booze; Charles F Mactutus
Journal:  J Vis Exp       Date:  2019-04-19       Impact factor: 1.355

8.  Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters.

Authors:  Sylvia Fitting; Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus
Journal:  Int J Dev Neurosci       Date:  2017-10-27       Impact factor: 2.457

9.  Unraveling Individual Differences In The HIV-1 Transgenic Rat: Therapeutic Efficacy Of Methylphenidate.

Authors:  Kristen A McLaurin; Hailong Li; Rosemarie M Booze; Amanda J Fairchild; Charles F Mactutus
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

10.  Sex Matters: Robust Sex Differences in Signal Detection in the HIV-1 Transgenic Rat.

Authors:  Kristen A McLaurin; Rosemarie M Booze; Charles F Mactutus; Amanda J Fairchild
Journal:  Front Behav Neurosci       Date:  2017-11-06       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.